Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm(TM) (dibutepinephrine) Sublingual Film
August 10, 2026
Health
-
-
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
August 7, 2026
-
Glucotrack Announces $5.5 Million Financing
August 5, 2026
-
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
August 5, 2026
-
InfuSystem Announces Financial Results for Second Quarter 2026
August 4, 2026
-
Butterfly Network Reports Second Quarter 2026 Financial Results
July 30, 2026
-
Jushi Holdings Provides Update on Plan of Arrangement
July 29, 2026
-
OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development
July 28, 2026
-
Lifecore Biomedical Signs Three New Customer Agreements
July 28, 2026
-
Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.
July 27, 2026
-
bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung
July 27, 2026
-
PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
July 23, 2026
-
FLUENT Announces Definitive Agreement to Sell New York License and Certain Operations
July 23, 2026
-
Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
July 22, 2026
-
Auxly Announces 14:1 Share Consolidation
July 22, 2026
-
Planet 13 Continues Strategic Florida Expansion with Upcoming Sarasota Store Opening
July 22, 2026